What should I know first?

Tobacco use disorder is more than a habit someone could simply abandon by trying harder. It involves a pattern of impaired control and continued use despite significant consequences. Nicotine is central to dependence, while many serious harms of smoking come from other components of tobacco smoke.

Products differ: cigarettes, smokeless tobacco and electronic nicotine products are not interchangeable. ICD-11 uses a nicotine-focused framework, so terminology may differ between records. This article includes relevant nicotine-dependence concepts while making clear which treatment evidence concerns smoking cessation.

Signs and Symptoms

Signs can include strong urges, repeated unsuccessful attempts to stop, using more than intended and continuing despite health or daily-life consequences. Some people organize routines around opportunities to use nicotine. Withdrawal can involve irritability, difficulty concentrating, restlessness, sleep disturbance and increased appetite.

The pattern differs between people and products. Physical dependence and craving are important, but diagnosis considers the wider effects on functioning. A person may need cessation support before meeting a formal disorder threshold. Concerns should be discussed without assuming that a visible smoking pattern reveals every aspect of severity.

How Is It Diagnosed?

Clinicians ask which products are used, how often, when urges occur, previous attempts to change and what made those attempts difficult. They assess consequences and coexisting health conditions, including mental health. Nicotine withdrawal is distinguished from an independent mood, sleep or attention problem, although both can occur.

Different classification systems may use tobacco-use or nicotine-dependence language. The diagnosis is clinical; a laboratory marker of exposure does not establish impaired control by itself. Planning treatment also requires knowing whether the person smokes, vapes, uses smokeless tobacco or combines products.

How Common Is It?

Tobacco exposure is common worldwide, but smoking rates, nicotine-product use and diagnosable tobacco use disorder are different measures. Estimates vary by age, country, product and assessment method. A survey of cigarette smoking cannot fully describe vaping-related dependence or all nicotine use.

Likewise, disease and death statistics describe the consequences of exposure rather than the prevalence of the psychiatric diagnosis. This article therefore avoids assigning one universal percentage to the disorder. The clinically useful question is how a person's pattern affects control, health and daily life.

What Causes It?

Nicotine's reinforcing effects interact with routines, stress, social surroundings, product availability and marketing. Repeated use can link everyday cues, such as breaks or social situations, with strong urges. Younger people may be particularly vulnerable to developing dependence. Distress and mental health difficulties can make stopping harder, while inadequate access to treatment can prolong exposure.

These influences explain why support matters; they do not mean a person lacks character or cannot change. Treatment explores both the physical pull of nicotine and the situations that maintain use.

What Do We Know About the Brain?

Nicotine affects brain processes involved in reward, attention and arousal. With repeated exposure, the brain adapts, and stopping can temporarily disrupt concentration, mood and comfort. Learned cues can continue to prompt urges even after the most immediate withdrawal has eased.

This helps explain why repeated attempts may be necessary and why both medicines and behavioral support can help. Brain science does not provide a routine scan for diagnosing the disorder. Recovery also depends on environmental changes and accessible support, not only on understanding biological adaptation.

Conditions With Similar Symptoms

Withdrawal can resemble anxiety, low mood, sleep disturbance or attention difficulties. Those symptoms should be considered in relation to changes in nicotine use without assuming that every symptom is temporary withdrawal. Independent psychiatric and medical conditions may also need care.

Nicotine poisoning after an unintended exposure is an acute medical problem, not evidence of a chronic use disorder. The health effects of tobacco smoke are also distinct from nicotine dependence, even though they are closely related. Identifying the product helps prevent misleading comparisons between these problems.

Other Conditions That Can Occur Together

Depression, anxiety and other substance use disorders can occur with tobacco use disorder. Smoking-related lung, cardiovascular and other diseases may also shape treatment needs. These conditions should be addressed together rather than requiring mental health symptoms to disappear before cessation support is offered.

People taking medicines or receiving care for pregnancy or other medical circumstances should discuss their cessation plan with a clinician. The goal is to select appropriate support and follow-up, not to assume that one product or medicine is suitable for everyone.

Treatment and Support

Behavioral support helps people recognize triggers, plan alternatives and learn from previous attempts. A clear plan can include follow-up, social support and coping strategies for cravings. FDA recommends approved cessation products together with counseling as a first-line approach for adults who smoke.

People who do not use tobacco should not begin using another nicotine product in the name of harm reduction. For someone who smokes, complete cessation provides the greatest benefit. Continuing to smoke while adding another product should not be described as eliminating smoking-related risk.

Can Medication Help?

FDA-approved smoking-cessation options include nicotine replacement, bupropion and varenicline. They work in different ways and have different precautions; an appropriate choice depends on the person's health, age, other medicines and preferences. An approval for smoking cessation should not be silently extended to every product, age group or nicotine-use pattern.

Nicotine replacement delivers nicotine without cigarette smoke and is not equivalent to continued smoking. Electronic cigarettes are not FDA-approved cessation medicines, even when individual products have marketing authorization. A clinician or pharmacist can explain suitable options without relying on unsupervised dosing advice.

Nicotine replacement is not FDA-approved for people younger than 18. AAP guidance allows pediatricians to consider it off-label for youth with moderate or severe nicotine dependence who want to quit, together with behavioral counseling and close follow-up. Under-18s need clinician prescribing and product-specific instructions; adult over-the-counter directions should not become a self-treatment plan.

What to Expect Over Time

Many people make more than one attempt before maintaining change. A return to use can reveal a trigger or support gap, not prove that treatment has failed permanently. Withdrawal and urges may change over time, and follow-up can help adjust the plan.

Improvements in health can occur after smoking stops, while established illnesses may still require ongoing care. Progress should include reduced harm and increased control, with honest discussion of continued exposure. No single timetable describes every person's recovery or the improvement of every smoking-related health problem.

Everyday Life and Support

Plan for familiar triggers, ask supportive people for help and keep follow-up appointments after the initial decision to quit. A lapse is a reason to reconnect with care rather than hide it. Store nicotine products securely away from children and pets; accidental exposure can be dangerous.

Avoid exposing other people to tobacco smoke. Contact emergency services immediately for collapse, severe breathing problems, seizures or inability to awaken. For suspected nicotine poisoning without these signs, contact a poison service or healthcare professional promptly. Decisions about cessation medicines should be discussed in the context of the actual product being used and the person's health.

History

Tobacco has a long cultural and commercial history, and recognition of its health harms and addictive properties changed medical practice. Older clinical records often used nicotine dependence, while DSM-5 introduced tobacco use disorder using the broader substance-use framework. ICD-11 continues to organize relevant diagnoses around nicotine.

Treatment has expanded beyond advice to stop, with behavioral support and several approved smoking-cessation medicines. More recently, electronic cigarettes and other products have complicated the public discussion of risk. Lower risk than combustible cigarettes does not mean harmless, and authorization to market a tobacco product is not the same as approval as a cessation medicine.

Historical terminology should therefore be interpreted alongside the actual product and current evidence.

Sources and References

These references separate nicotine dependence, smoking-related harms and the evidence for cessation treatments. Product marketing authorization and medicinal approval mean different things. Terminology also differs between DSM and ICD classifications.

  1. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)
  2. The Relative Risks of Tobacco Products
  3. What Is a Substance Use Disorder? (physician review 2024-04)
  4. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)
  5. Want to Quit Smoking? FDA-Approved and FDA-Cleared Cessation Products Can Help
  6. Properly Store Nicotine Pouches to Prevent Accidental Exposure to Children and Pets
  7. Nicotine Replacement Therapy and Adolescent Patients
  8. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top